Eu Med Services Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-11-2024
- Paid Up Capital ₹ 0.50 M
as on 16-11-2024
- Company Age 12 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 Cr
as on 16-11-2024
- Revenue -64.70%
(FY 2023)
- Profit -386.00%
(FY 2023)
- Ebitda -1173.08%
(FY 2023)
- Net Worth -664.30%
(FY 2023)
- Total Assets -46.54%
(FY 2023)
About Eu Med Services
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹2.00 Cr.
Joy Sukumaran and Raju Kadamatt serve as directors at the Company.
- CIN/LLPIN
U51397KL2012PTC032002
- Company No.
032002
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Aug 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Eu Med Services Private Limited offer?
Eu Med Services Private Limited offers a wide range of products and services, including Syringes, Oxygen Mask, Nebulizer Mask, Anaesthetic Face Mask, Disposable Gloves, Surgical Gloves, Examination Gloves, Surgical & ICU Equipments, Ventilator Parts & Consumables, Medical Tubes.
Who are the key members and board of directors at Eu Med Services?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raju Kadamatt  | Managing Director | 30-Aug-2012 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Joy Sukumaran | Whole-Time Director | 30-Aug-2012 | Current |
Financial Performance of Eu Med Services.
Eu Med Services Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 64.7% decrease. The company also saw a substantial fall in profitability, with a 386% decrease in profit. The company's net worth observed a substantial decline by a decrease of 664.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eu Med Services?
In 2023, Eu Med Services had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 07 Jun 2016 | ₹2.00 Cr | Open |
How Many Employees Work at Eu Med Services?
Unlock and access historical data on people associated with Eu Med Services, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eu Med Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eu Med Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
